Vytorin Clinical Trials Vytorin RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

An OS to Evaluate the Safety & Efficacy of Fixed Dose Combination Therapy With Atorvastatin and Ezetimibe
Condition:   Primary Hypercholesterolemia Intervention:   Sponsor:   Boryung Pharmaceutical Co., Ltd Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 29, 2022 Category: Research Source Type: clinical trials